LabPulse.com staff writersFDA ClearanceLeica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology systemLeica Biosystems has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aperio GT 450 DX digital pathology system, in conjunction with Sectra's digital pathology software.May 2, 2024Research AllianceGSK, Genomics PLC collaborate on polygenic risk score use for clinical trialsGenomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.May 1, 2024Pathology and AIQuest Diagnostics to add digital pathology lab, AI pathology center in TennesseeQuest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.May 1, 2024FinancingVariantyx raises $36M in fundingPrecision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.April 30, 2024Mergers & AcquisitionsLabcorp buys Invitae portfolio for $239MLabcorp was the winning bidder in the court-supervised auction of Invitae's assets, obtaining substantially all of the San Francisco-based company's business for $239 million in cash consideration with other noncash consideration.April 26, 2024Financial ResultsBristol Myers Squibb to reduce workforce in restructuring planAs part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.April 25, 2024ValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.April 25, 2024CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyAs part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.April 25, 2024LawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitThe Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.April 24, 2024Alzheimer'sQuest adds new biomarker test to Alzheimer's portfolioQuest Diagnostics has launched a new blood biomarker test as part of its AD-Detect portfolio of blood tests for Alzheimer's disease risk assessment.April 23, 2024Previous PagePage 2 of 342Next PageTop StoriesConcussionDanaher launches collaboration with Johns Hopkins University on TBI diagnosticsDanaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.PCRQiagen partners with FBI on forensics assayImmunoassaysUniversity of Florida researchers develop CRISPR-based assay for HPV detectionFDA ClearanceGeneoscopy receives FDA approval for CRC screening testSponsor ContentVisit our Molecular Diagnostics Community